financetom
Business
financetom
/
Business
/
KKR's quarterly profit beats estimates on rising inflows
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KKR's quarterly profit beats estimates on rising inflows
Nov 7, 2025 4:17 AM

Nov 7 (Reuters) - KKR reported a rise in

third-quarter profit that beat Wall Street's expectations on

Friday, boosted by strong fundraising, particularly in its

insurance unit and credit.

Adjusted net income of $1.27 billion, or $1.41 per share,

surpassed the $1.17 billion, or $1.30 per share, which analysts

on average had expected from the New York-based alternative

asset manager, according to estimates compiled by LSEG.

Fee-related earnings, which reflect fees charged for

managing a growing stash of assets, rose to $1 billion. Total

assets rose to $723 billion on the back of $43 billion in fresh

capital raised in the quarter.

KKR's co-CEOs Scott Nuttall and Joe Bae have set a target

for assets to reach $1 trillion by 2030.

Transaction fees from the capital markets business, which

arranges financing for companies in its portfolio and for

clients dipped 35% from a year ago to $276 million.

Along with peers Blackstone, whose assets have

breached the $1 trillion mark, and Apollo, which hopes

to get there by 2026, KKR has added new business lines to grow

beyond the traditional private equity strategy of buying and

selling businesses.

Private equity firms have been all the keener to branch out

as higher interest rates and market volatility hampered their

ability to profit from selling companies they bought during a

long period of lower rates at prices that in some cases now look

expensive.

Among those newer businesses, insurer Global Atlantic, which

represents a third of the firm's assets, saw operating earnings

rise 28%.

Analysts have been watching the retirement segments at KKR

and Apollo for any signs of strain on profits from selling

annuities, which are sold for a lump sum and guarantee periodic

payouts.

KKR also tapped the wealthy individuals who alternative

investment firms are increasingly targeting. Its K-Series

business offering funds to retail investors grew to $29 billion

from $14 billion a year ago.

One result of the generally slower pace of exiting private

equity investments through sales or refinancing has been a

squeeze on private equity funds' ability to return capital to

their investors.

In turn, some of them have become reluctant to make

commitments to new funds. KKR said on Friday it has raised $17.5

billion for its latest North America-focused fund, which people

familiar with the matter said last summer had started marketing

to investors with a target of around $20 billion.

Dry powder, or money investors have pledged but has not yet

been used, totaled $126 billion. During the quarter, KKR closed

a deal to buy a majority stake in biopharma royalty acquisition

company Healthcare Royalty Partners.

Global Atlantic received a $2 billion investment from Japan

Post Insurance Company.

After the end of the quarter, KKR teamed up with Apollo to

invest $7 billion in Keurig Dr Pepper ( KDP ), a deal which

helped ease investor concerns about the beverage group's debt

pile after it bought coffee maker JDE Peet's.

(Reporting by Isla Binnie in New York and Arasu Kannagi Basil

in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Says Phase 2 Trial for Zilebesiran Meets Primary Endpoint
Alnylam Pharmaceuticals Says Phase 2 Trial for Zilebesiran Meets Primary Endpoint
Apr 8, 2024
06:10 AM EDT, 04/08/2024 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) said Sunday that a phase 2 study evaluating the investigational drug zilebesiran in treating hypertension has met its primary endpoint. Zilebesiran reached the study's primary endpoint after demonstrating statistically significant reductions in systolic blood pressure in three months, the company said. Most laboratory abnormalities of interest were mild,...
Guyana gas-to-power project to shave weeks off oil output, hit revenue
Guyana gas-to-power project to shave weeks off oil output, hit revenue
Apr 8, 2024
GEORGETOWN (Reuters) - Guyana's efforts to use its natural gas resources to fuel a power plant that would slash the South American nation's energy costs have snagged on construction delays and threaten to curtail the rising oil hotspot's revenue this year by about $1 billion. The $1.9 billion gas-to-power project, Guyana's biggest effort to capitalize on its energy bounty, is...
Ibotta plans to raise up to $473 mln in US IPO
Ibotta plans to raise up to $473 mln in US IPO
Apr 8, 2024
April 8 (Reuters) - Digital marketing company Ibotta said on Monday it was targeting to raise up to $472.5 million in its U.S. initial public offering. ...
Major food companies offering deals, new sizes as low-income Americans spend less
Major food companies offering deals, new sizes as low-income Americans spend less
Apr 8, 2024
NEW YORK (Reuters) - Americans relying on government benefits to buy food and other essentials are slashing spending, prompting food makers like Kraft-Heinz ( KHC ) and Conagra Brands ( CAG ) to overhaul their products and strategies following years of price hikes. Many of the biggest makers of packaged foods and drinks are seeing their sales volumes fall, due...
Copyright 2023-2026 - www.financetom.com All Rights Reserved